India Cardiovascular Devices Market, By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, and Competition, Forecast & Opportunities, 2020-2030F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIndia Cardiovascular Devices Market, By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, and Competition, Forecast & Opportunities, 2020-2030F
| Forecast Period | 2026-2030 |
| Market Size (2024) | USD 1599.70 Million |
| Market Size (2030) | USD 2427.89 Million |
| CAGR (2025-2030) | 7.16% |
| Fastest Growing Segment | Surgical Devices |
| Largest Market | North India |
Market Overview
India Cardiovascular Devices Market has valued at USD 1599.70 million in 2024 and is anticipated to reach USD 2427.89 Million by 2030, with a CAGR of 7.16% during 2025-2030.
The escalating prevalence of cardiovascular diseases in India, such as heart disease and hypertension, serves as a key growth driver, fueling demand for cardiovascular devices for diagnostic and therapeutic purposes. Government-sponsored healthcare programs and initiatives targeting the mounting burden of cardiovascular ailments have the potential to further stimulate demand for cardiovascular devices by allocating funds for medical equipment and infrastructure enhancements. The proliferation of healthcare infrastructure, encompassing hospitals and specialized cardiac care centers, also contributes to market growth, as these facilities necessitate a diverse array of cardiovascular devices for comprehensive diagnosis and treatment protocols.
A burgeoning awareness of cardiovascular health in India, fostered by awareness campaigns, educational endeavors, and preventive measures, underscores the rising demand for diagnostic and monitoring devices tailored to cardiovascular health management. Regulatory dynamics and evolving standards governing medical devices in India exert a substantial influence on the approval and commercialization of cardiovascular devices. Manufacturers must adhere to these regulations to gain entry and thrive in the market landscape.
Key Market Drivers
Technological Advancements
Stents are pivotal in treating coronary artery disease, with advancements yielding drug-eluting stents (DES) and bioresorbable alternatives for enhanced patient outcomes. Catheterization techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) offer precise coronary artery imaging, aiding in diagnosis and treatment. Robotic-assisted and minimally invasive procedures reduce recovery time and complications. Innovative imaging technologies such as cardiac MRI and 3D echocardiography facilitate accurate diagnosis and treatment planning. Implantable devices like pacemakers and defibrillators, now with remote monitoring capabilities, effectively manage heart rhythm disorders.
AI and machine learning analyze patient data for early detection and personalized treatment plans. Telemedicine integration enables remote consultations, especially in underserved areas. Wearable devices monitor heart health and provide real-time data. Mobile apps support remote cardiac rehabilitation programs. 3D printing creates patient-specific cardiac models and custom implants. Nanotechnology aids in drug delivery systems and diagnostic tools for early disease detection. Gene therapy research targets genetic factors underlying cardiovascular diseases. Biodegradable materials minimize long-term complications, while remote monitoring devices assist heart failure patients, reducing hospital readmissions, thus fostering growth in the India Cardiovascular Devices Market.
Rising Aging Population
With advancing age, the prevalence of cardiovascular diseases such as coronary artery disease, heart failure, and atrial fibrillation rises, necessitating increased cardiovascular monitoring and treatment among the aging population. Hypertension, a common condition among older individuals, is a major risk factor for cardiovascular ailments, often necessitating the use of blood pressure monitors and other cardiovascular devices for monitoring and management.
Age-related conditions like aortic stenosis, characterized by the narrowing of the aortic valve, become more prevalent with aging, often requiring valve replacement devices. Implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices are frequently employed in older populations to manage cardiac arrhythmias like atrial fibrillation.
Given potential mobility and transportation challenges among the aging population, telemedicine and remote monitoring solutions, including wearable and implantable monitors, are instrumental in providing accessible healthcare. Heart failure, prevalent in the elderly, is managed using implantable devices like ICDs and CRT devices.
Increasing Awareness and Prevention Efforts
Awareness campaigns and preventive measures play a pivotal role in educating the population about the risk factors and warning signs of cardiovascular diseases. This heightened awareness encourages individuals to seek early diagnosis, often facilitated by the use of cardiovascular devices such as blood pressure monitors and ECG machines. Health education initiatives promote healthier lifestyles, including dietary improvements and regular physical activity, which can mitigate the risk of cardiovascular diseases, emphasizing prevention as a crucial aspect of healthcare.
Individuals who are aware of their cardiovascular risk factors, such as hypertension or elevated cholesterol levels, are more inclined to utilize monitoring devices at home, including wearable fitness trackers and blood pressure monitors, for self-assessment. Screening and check-up programs, integral to awareness initiatives, offer access to diagnostic tests and assessments using cardiovascular devices, aiding in early detection of risk factors and conditions.
Government and public health organizations drive initiatives to promote cardiovascular health, including the distribution of diagnostic devices like blood pressure monitors to underserved communities. Healthcare professionals are also targeted for education on the latest advancements in cardiovascular devices and treatment options, subsequently informing patients. Community and workplace awareness programs integrate preventive interventions and wellness initiatives, often incorporating fitness trackers and other devices for monitoring physical activity and heart health.
Key Market Challenges
Cost and Affordability
The costliness of many cardiovascular devices, including implantable pacemakers, stents, and advanced diagnostic equipment, presents a significant hurdle for both patients and healthcare facilities, impacting the adoption of these devices. India's population exhibits diverse income levels, with a considerable segment falling within the low to middle-income brackets. For individuals in these economic strata, the expense associated with cardiovascular devices often proves prohibitive.
Health insurance coverage remains incomplete, leaving many patients to cover medical expenses out of pocket. Consequently, the high out-of-pocket costs linked with cardiovascular procedures and devices dissuade individuals from seeking timely medical attention. In rural areas, where access to specialized cardiac care is limited, patients encounter additional financial burdens associated with travel and accommodation when seeking treatment in urban centers.
Many individuals lack adequate health insurance coverage for cardiovascular procedures or devices, leaving them to shoulder the entirety of the financial burden. While government healthcare initiatives exist, funding may fall short of addressing the population's cardiovascular device needs, exacerbating affordability challenges.
Import Dependence
The reliance on imports exposes the market to foreign currency exchange rate fluctuations. Variations in exchange rates can significantly impact the cost of imported devices, potentially making them more expensive for Indian consumers and healthcare providers. Importing medical devices often involves additional costs, such as import tariffs and customs duties. These additional expenses can increase the overall cost of cardiovascular devices, making them less affordable for end-users. Relying on imports makes the supply chain more vulnerable to disruptions, such as global economic downturns, geopolitical tensions, and trade disputes. These disruptions can lead to delays in the availability of cardiovascular devices in the Indian market. Importing devices can lead to higher device costs, which can be a barrier for both healthcare facilities and patients. The increased cost of imported devices may limit their accessibility to a broader population. Ensuring the quality and safety of imported cardiovascular devices can be challenging due to variations in regulations and standards in different countries. Regulatory compliance and quality control measures are critical to protect patient safety. Dependence on foreign manufacturers means that the Indian market has limited control over the production and supply of cardiovascular devices. This can lead to uncertainty in device availability and pricing.
Key Market Trends
Shift Towards Minimally Invasive Procedures
Patients often prefer minimally invasive procedures over traditional open-heart surgeries because they typically involve smaller incisions, less pain, shorter hospital stays, and quicker recovery times. Minimally invasive procedures involve smaller incisions and are less disruptive to the body. This can lead to fewer complications, reduced scarring, and a quicker return to daily activities. Technological advancements have made minimally invasive techniques more feasible and effective. Devices like catheters, endoscopic tools, and imaging systems have improved precision and safety. Minimally invasive procedures can be more cost-effective for patients and healthcare providers due to shorter hospital stays and reduced post-operative care requirements. Minimally invasive procedures often carry lower risks of infection, bleeding, and complications, making them an attractive option for patients with multiple comorbidities. These procedures cause less trauma to the body, which can be particularly beneficial for older patients or those with frail health. Patients undergoing minimally invasive procedures typically experience faster recovery times and can return to their daily routines sooner. This is a crucial consideration for those who need to get back to work or caregiving responsibilities. Minimally invasive techniques have improved diagnostics and interventional procedures. These include percutaneous coronary interventions (PCI) like angioplasty and stent placement, which are essential for managing coronary artery disease. Minimally invasive procedures can often reach areas that are difficult to access through traditional surgery, making them particularly valuable for complex cases.
Segmental Insights
Type Insights
In 2024, the India Cardiovascular Devices Market largest share was held by Diagnostic & Monitoring Devices segment and is predicted to continue expanding over the coming years.
Application Insights
In 2024, the India Cardiovascular Devices Market largest share was held by coronary artery disease segment and is predicted to continue expanding over the coming years.
Regional Insights
The North India region dominates the India Cardiovascular Devices Market in 2024.
Recent Developments
- In April 2023, Researchers at the Indian Institute of Technology Madras have unveiled a groundbreaking non-invasive device, dubbed ARTSENS, aimed at assessing the health and age of blood vessels. This innovation offers early screening for cardiovascular diseases, enhancing preventive healthcare measures. ARTSENS is engineered to be user-friendly, enabling routine usage in medical examinations even by non-experts. Developed by the Healthcare Technology Innovation Centre (HTIC) at IIT Madras, the device integrates a proprietary non-imaging probe and an intelligent computing platform. It has undergone extensive testing on over 5,000 human subjects, demonstrating its efficacy. Furthermore, the technology boasts five utility patents in the U.S., European Union, and India, along with 10 design patents, and is awaiting approval for 28 patents across various jurisdictions.
- In September 2022, GE Healthcare has unveiled the Optima IGS 320, anAI-powered cath lab, marking its debut as a 'Made in India' offering. Thiscutting-edge interventional imaging software enhances cardiac care in thecountry, offering advanced features for precise non-invasive procedures. Theincorporation of AutoRight automation streamlines intricate processes, reducingthe workload on interventionalists and allowing them to focus more on theprocedure itself. The Optima IGS 320 isspecifically tailored for cardiac and electrophysiology procedures, enhancingimaging capabilities to facilitate intelligent and precise healthcare delivery.
Key Market Players
- India Medtronic Pvt Ltd
- Siemens Healthcare Private Limited
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- B. Braun Medical (India) Pvt. Ltd.
- Abbott India Limited
- Terumo India Private Limited
- Biotronik Medical Devices India Private Ltd.
- BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED
|
|
|
|
| · Coronary Artery Disease · Cardiac Arrhythmia · Heart Failure · Others | · Hospitals & Clinics · Diagnostic Centers · Others | · North India · South India · East India · West India |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy